[1]
|
Chen, P., Liu, Y., Wen, Y. and Zhou, C. (2022) Non‐Small Cell Lung Cancer in China. Cancer Communications, 42, 937-970. https://doi.org/10.1002/cac2.12359
|
[2]
|
Yang, Z., Wang, H., Zhao, Z., Jin, Y., Zhang, Z., Tan, J., et al. (2022) Gene-microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer. Genes, 13, Article 1480. https://doi.org/10.3390/genes13081480
|
[3]
|
National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine, 365, 395-409. https://doi.org/10.1056/nejmoa1102873
|
[4]
|
Moyer, V.A. (2014) Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 160, 330-338. https://doi.org/10.7326/m13-2771
|
[5]
|
Bach, P.B., Mirkin, J.N., Oliver, T.K., Azzoli, C.G., Berry, D.A., Brawley, O.W., et al. (2012) Benefits and Harms of CT Screening for Lung Cancer. JAMA, 307, 2418-2429. https://doi.org/10.1001/jama.2012.5521
|
[6]
|
Owens, C., Hindocha, S., Lee, R., Millard, T. and Sharma, B. (2023) The Lung Cancers: Staging and Response, CT, 18F-FDG PET/CT, MRI, DWI: Review and New Perspectives. The British Journal of Radiology, 96, Article ID: 20220339. https://doi.org/10.1259/bjr.20220339
|
[7]
|
Jet, T., Gines, G., Rondelez, Y. and Taly, V. (2021) Advances in Multiplexed Techniques for the Detection and Quantification of microRNAs. Chemical Society Reviews, 50, 4141-4161. https://doi.org/10.1039/d0cs00609b
|
[8]
|
Cheong, J.K., Tang, Y.C., Zhou, L., Cheng, H. and Too, H. (2022) Advances in Quantifying Circulatory microRNA for Early Disease Detection. Current Opinion in Biotechnology, 74, 256-262. https://doi.org/10.1016/j.copbio.2021.12.007
|
[9]
|
Baldasici, O., Pileczki, V., Cruceriu, D., Gavrilas, L.I., Tudoran, O., Balacescu, L., et al. (2022) Breast Cancer-Delivered Exosomal Mirna as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability. International Journal of Molecular Sciences, 23, Article 9371. https://doi.org/10.3390/ijms23169371
|
[10]
|
Ravegnini, G., Gorini, F., De Crescenzo, E., De Leo, A., De Biase, D., Di Stanislao, M., et al. (2021) Can mirnas Be Useful Biomarkers in Improving Prognostic Stratification in Endometrial Cancer Patients? An Update Review. International Journal of Cancer, 150, 1077-1090. https://doi.org/10.1002/ijc.33857
|
[11]
|
Khan, P., Ebenezer, N.S., Siddiqui, J.A., Maurya, S.K., Lakshmanan, I., Salgia, R., et al. (2022) MicroRNA-1: Diverse Role of a Small Player in Multiple Cancers. Seminars in Cell & Developmental Biology, 124, 114-126. https://doi.org/10.1016/j.semcdb.2021.05.020
|
[12]
|
Marcuello, M., Vymetalkova, V., Neves, R.P.L., Duran-Sanchon, S., Vedeld, H.M., Tham, E., et al. (2019) Circulating Biomarkers for Early Detection and Clinical Management of Colorectal Cancer. Molecular Aspects of Medicine, 69, 107-122. https://doi.org/10.1016/j.mam.2019.06.002
|
[13]
|
Friedman, R.C., Farh, K.K., Burge, C.B. and Bartel, D.P. (2008) Most Mammalian mRNAs Are Conserved Targets of microRNAs. Genome Research, 19, 92-105. https://doi.org/10.1101/gr.082701.108
|
[14]
|
Bartel, D.P. (2009) microRNAs: Target Recognition and Regulatory Functions. Cell, 136, 215-233. https://doi.org/10.1016/j.cell.2009.01.002
|
[15]
|
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14. Cell, 75, 843-854. https://doi.org/10.1016/0092-8674(93)90529-y
|
[16]
|
Martinez, M.A., Tural, C. and Franco, S. (2022) Circulating microRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses, 14, Article 1118. https://doi.org/10.3390/v14061118
|
[17]
|
El-Hefnawy, T., Raja, S., Kelly, L., Bigbee, W.L., Kirkwood, J.M., Luketich, J.D., et al. (2004) Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics. Clinical Chemistry, 50, 564-573. https://doi.org/10.1373/clinchem.2003.028506
|
[18]
|
Ho, P.T.B., Clark, I.M. and Le, L.T.T. (2022) microRNA-based Diagnosis and Therapy. International Journal of Molecular Sciences, 23, Article 7167. https://doi.org/10.3390/ijms23137167
|
[19]
|
Jeon, D.S., Kim, H.C., Kim, S.H., Kim, T., Kim, H.K., Moon, M.H., et al. (2023) Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer Research and Treatment, 55, 103-111. https://doi.org/10.4143/crt.2022.264
|
[20]
|
Ahn, Y. and Ko, Y.H. (2020) Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 21, Article 8782. https://doi.org/10.3390/ijms21228782
|
[21]
|
Wei, C., Zhang, R., Cai, Q., Gao, X., Tong, F., Dong, J., et al. (2019) microRNA-330-3P Promotes Brain Metastasis and Epithelial-Mesenchymal Transition via GRIA3 in Non-Small Cell Lung Cancer. Aging, 11, 6734-6761. https://doi.org/10.18632/aging.102201
|
[22]
|
Liu, B. and Sun, X. (2019) miR-25 Promotes Invasion of Human Non-Small Cell Lung Cancer via CDH1. Bioengineered, 10, 271-281. https://doi.org/10.1080/21655979.2019.1632668
|
[23]
|
Wu, T., Hu, H., Zhang, T., Jiang, L., Li, X., Liu, S., et al. (2019) miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 9719723. https://doi.org/10.1155/2019/9719723
|
[24]
|
Zhang, Y., Yuan, J., Guo, M., Xiang, R., Wang, X., Xie, T., et al. (2022) miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction. Disease Markers, 2022, Article ID: 4842454. https://doi.org/10.1155/2022/4842454
|
[25]
|
Huang, X., Xiao, S., Zhu, X., Yu, Y., Cao, M., Zhang, X., et al. (2020) miR-196B-5P-mediated Downregulation of FAS Promotes NSCLC Progression by Activating IL6-STAT3 Signaling. Cell Death & Disease, 11, Article No. 785. https://doi.org/10.1038/s41419-020-02997-7
|
[26]
|
Zhang, P., Li, L., Wang, B., Ran, X., Yang, S., Luo, Y., et al. (2022) miR-489-3p Promotes Malignant Progression of Non-Small Cell Lung Cancer through the Inactivation of Wnt/β-Catenin Signaling Pathway via Regulating USP48. Respiratory Research, 23, Article No. 93. https://doi.org/10.1186/s12931-022-01988-w
|
[27]
|
Zeng, X., Liu, D., Peng, G., Liu, J. and Yang, H. (2022) Mirorna-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1). Computational and Mathematical Methods in Medicine, 2022, Article ID: 4597087. https://doi.org/10.1155/2022/4597087
|
[28]
|
Han, L., Zhang, Y., Zhao, B., Yue, J., Chen, Z., Lei, G., et al. (2022) MicroRNA 101 Attenuated NSCLC Proliferation through IDH2/HIFα Axis Suppression in the Warburg Effect. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 4938811. https://doi.org/10.1155/2022/4938811
|
[29]
|
Shi, J., Wang, H., Feng, W., Huang, S., An, J., Qiu, Y., et al. (2020) MicroRNA-130a Targeting Hypoxia-Inducible Factor 1 α Suppresses Cell Metastasis and Warburg Effect of NSCLC Cells under Hypoxia. Life Sciences, 255, Article ID: 117826. https://doi.org/10.1016/j.lfs.2020.117826
|
[30]
|
Liu, J., Jia, Y., Jia, L., Li, T., Yang, L. and Zhang, G. (2019) MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 27, 269-279. https://doi.org/10.3727/096504018x15215019227688
|
[31]
|
Jiang, F., Yu, Q., Chu, Y., Zhu, X., Lu, W., Liu, Q., et al. (2018) MicroRNA-98-5p Inhibits Proliferation and Metastasis in Non-Small Cell Lung Cancer by Targeting TGFBR1. International Journal of Oncology, 54, 128-138. https://doi.org/10.3892/ijo.2018.4610
|
[32]
|
Lu, G. and Zhang, Y. (2019) MicroRNA-340-5p Suppresses Non-Small Cell Lung Cancer Cell Growth and Metastasis by Targeting ZNF503. Cellular & Molecular Biology Letters, 24, Article No. 34. https://doi.org/10.1186/s11658-019-0161-1
|
[33]
|
Gao, J., Feng, X., Wang, F., Wang, J., Wang, H., Li, H., et al. (2019) MicroRNA-448 Inhibits the Progression of Non‐Small-Cell Lung Cancer through Regulating IRS2. Journal of Cellular Biochemistry, 120, 13453-13463. https://doi.org/10.1002/jcb.28619
|
[34]
|
Huang, R., Zheng, Y., Li, C., Ding, C., Xu, C. and Zhao, J. (2018) MicroRNA-485-5p Suppresses Growth and Metastasis in Non-Small Cell Lung Cancer Cells by Targeting IGF2BP2. Life Sciences, 199, 104-111. https://doi.org/10.1016/j.lfs.2018.03.005
|
[35]
|
Bai, X., He, C., Fu, B., Kong, X., Bu, J., Zhu, K., et al. (2020) MicroRNA-877 Contributes to Decreased Non-Small Cell Lung Cancer Cell Growth via the PI3K/AKT Pathway by Targeting Tartrate Resistant Acid Phosphatase 5 Activity. Cell Cycle, 19, 3260-3276. https://doi.org/10.1080/15384101.2020.1839697
|
[36]
|
Khandelwal, A., Sharma, U., Barwal, T.S., Seam, R.K., Gupta, M., Rana, M.K., et al. (2021) Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-Small Cell Lung Cancer. Frontiers in Oncology, 11, Article 645475. https://doi.org/10.3389/fonc.2021.645475
|
[37]
|
Liu, F., Li, T., Hu, P. and Dai, L. (2021) Upregulation of Serum Mir-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer. Disease Markers, 2021, Article ID: 8819934. https://doi.org/10.1155/2021/8819934
|
[38]
|
Soliman, S.E., Abdelaleem, A.H., Alhanafy, A.M., Ibrahem, R.A.L., Elhaded, A.S.A. and Assar, M.F.A. (2021) Circulating miR-21-5p and miR-126-3p: Diagnostic, Prognostic Value, and Multivariate Analysis in Non-Small-Cell Lung Cancer. Molecular Biology Reports, 48, 2543-2552. https://doi.org/10.1007/s11033-021-06302-3
|
[39]
|
Chen, L., Li, Y. and Lu, J. (2020) Identification of Circulating Mir-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment, 19. https://doi.org/10.1177/1533033820964222
|
[40]
|
Torres, A.G., Fabani, M.M., Vigorito, E. and Gait, M.J. (2011) MicroRNA Fate upon Targeting with Anti-Mirna Oligonucleotides as Revealed by an Improved Northern-Blot-Based Method for miRNA Detection. RNA, 17, 933-943. https://doi.org/10.1261/rna.2533811
|
[41]
|
Gines, G., Menezes, R., Xiao, W., Rondelez, Y. and Taly, V. (2020) Emerging Isothermal Amplification Technologies for MicroRNA Biosensing: Applications to Liquid Biopsies. Molecular Aspects of Medicine, 72, Article ID: 100832. https://doi.org/10.1016/j.mam.2019.11.002
|
[42]
|
Tiberio, P., Callari, M., Angeloni, V., Daidone, M.G. and Appierto, V. (2015) Challenges in Using Circulating miRNAs as Cancer Biomarkers. BioMed Research International, 2015, Article ID: 731479. https://doi.org/10.1155/2015/731479
|
[43]
|
Brittain, W.J., Brandsetter, T., Prucker, O. and Rühe, J. (2019) The Surface Science of Microarray Generation—A Critical Inventory. ACS Applied Materials & Interfaces, 11, 39397-39409. https://doi.org/10.1021/acsami.9b06838
|
[44]
|
Wong, R.K.Y., MacMahon, M., Woodside, J.V. and Simpson, D.A. (2019) A Comparison of RNA Extraction and Sequencing Protocols for Detection of Small RNAs in Plasma. BMC Genomics, 20, Article No. 446. https://doi.org/10.1186/s12864-019-5826-7
|
[45]
|
Ali, M.M., Li, F., Zhang, Z., Zhang, K., Kang, D., Ankrum, J.A., et al. (2014) Rolling Circle Amplification: A Versatile Tool for Chemical Biology, Materials Science and Medicine. Chemical Society Reviews, 43, 3324-3341. https://doi.org/10.1039/c3cs60439j
|
[46]
|
Xu, L., Duan, J., Chen, J., Ding, S. and Cheng, W. (2021) Recent Advances in Rolling Circle Amplification-Based Biosensing Strategies—A Review. Analytica Chimica Acta, 1148, 238187. https://doi.org/10.1016/j.aca.2020.12.062
|
[47]
|
Das, S., Devireddy, R. and Gartia, M.R. (2023) Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection. Biosensors, 13, Article 396. https://doi.org/10.3390/bios13030396
|
[48]
|
Singh, G.P. and Sardana, N. (2022) Smartphone-based Surface Plasmon Resonance Sensors: A Review. Plasmonics, 17, 1869-1888. https://doi.org/10.1007/s11468-022-01672-1
|
[49]
|
Guo, X., Li, J., Arabi, M., Wang, X., Wang, Y. and Chen, L. (2020) Molecular-Imprinting-Based Surface-Enhanced Raman Scattering Sensors. ACS Sensors, 5, 601-619. https://doi.org/10.1021/acssensors.9b02039
|
[50]
|
Li, M., Qiu, Y., Fan, C., Cui, K., Zhang, Y. and Xiao, Z. (2018) Design of SERS Nanoprobes for Raman Imaging: Materials, Critical Factors and Architectures. Acta Pharmaceutica Sinica B, 8, 381-389. https://doi.org/10.1016/j.apsb.2018.01.010
|
[51]
|
Wu, J., Zhou, X., Li, P., Lin, X., Wang, J., Hu, Z., et al. (2021) Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Analytical Chemistry, 93, 8799-8809. https://doi.org/10.1021/acs.analchem.1c00478
|
[52]
|
Kirschner, M.B., Kao, S.C., Edelman, J.J., Armstrong, N.J., Vallely, M.P., van Zandwijk, N., et al. (2011) Haemolysis during Sample Preparation Alters MicroRNA Content of Plasma. PLOS ONE, 6, e24145. https://doi.org/10.1371/journal.pone.0024145
|
[53]
|
Cheng, H.H., Yi, H.S., Kim, Y., Kroh, E.M., Chien, J.W., Eaton, K.D., et al. (2013) Plasma Processing Conditions Substantially Influence Circulating MicroRNA Biomarker Levels. PLOS ONE, 8, e64795. https://doi.org/10.1371/journal.pone.0064795
|
[54]
|
Mestdagh, P., Hartmann, N., Baeriswyl, L., Andreasen, D., Bernard, N., Chen, C., et al. (2014) Evaluation of Quantitative Mirna Expression Platforms in the MicroRNA Quality Control (miRQC) Study. Nature Methods, 11, 809-815. https://doi.org/10.1038/nmeth.3014
|
[55]
|
Fehlmann, T., Lehallier, B., Schaum, N., Hahn, O., Kahraman, M., Li, Y., et al. (2020) Common Diseases Alter the Physiological Age-Related Blood MicroRNA Profile. Nature Communications, 11, Article No. 5958. https://doi.org/10.1038/s41467-020-19665-1
|